Search results

    Filter results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 10
Number of items: 10
  • Open Access
    Verhoog, Q. P., Holtman, L., Aronica, E., & van Vliet, E. A. (2020). Astrocytes as Guardians of Neuronal Excitability: Mechanisms Underlying Epileptogenesis. Frontiers in Neurology, 11, Article 591690. https://doi.org/10.3389/fneur.2020.591690
  • Holtman, L., van Vliet, E., Appeldoorn, C., Gaillard, P. J., de Boer, M., Dorland, R., Wadman, W., & Gorter, J. (2014). Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat. Epilepsy Research, 108(3), 396-404. https://doi.org/10.1016/j.eplepsyres.2014.01.010
  • Holtman, L., van Vliet, E. A., Aronica, E., Wouters, D., Wadman, W. J., & Gorter, J. A. (2013). Blood plasma inflammation markers during epileptogenesis in post-status epilepticus rat model for temporal lobe epilepsy. Epilepsia, 54(4), 589-595. https://doi.org/10.1111/epi.12112
  • Open Access
    Holtman, L. (2013). Anti-inflammatory strategies during epileptogenesis. [Thesis, fully internal, Universiteit van Amsterdam].
  • van Vliet, E. A., Forte, G., Holtman, L., den Burger, J. C. G., Sinjewel, A., de Vries, H. E., Aronica, E., & Gorter, J. A. (2012). Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation. Epilepsia, 53(7), 1254-1263. https://doi.org/10.1111/j.1528-1167.2012.03513.x
  • van Vliet, E. A., Holtman, L., Aronica, E., Schmitz, L. J. M., Wadman, W. J., & Gorter, J. A. (2011). Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy. Epilepsia, 52(7), 1319-1330. https://doi.org/10.1111/j.1528-1167.2011.03073.x
  • Holtman, L., van Vliet, E. A., Baas, F., Aronica, E., & Gorter, J. A. (2011). Complement protein 6 deficiency in PVG/c rats does not lead to neuroprotection against seizure induced cell death. Neuroscience, 188, 109-116. https://doi.org/10.1016/j.neuroscience.2011.05.003
  • van Vliet, E. A., Zibell, G., Pekcec, A., Schlichtiger, J., Edelbroek, P. M., Holtman, L., Aronica, E., Gorter, J. A., & Potschka, H. (2010). COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology, 58(2), 404-412. https://doi.org/10.1016/j.neuropharm.2009.09.012
  • Holtman, L., van Vliet, E. A., Edelbroek, P. M., Aronica, E., & Gorter, J. A. (2010). Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Research, 91(1), 49-56. https://doi.org/10.1016/j.eplepsyres.2010.06.011
  • Holtman, L., van Vliet, E. A., van Schaik, R., Queiroz, C. M., Aronica, E., & Gorter, J. A. (2009). Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Research, 84(1), 56-66. https://doi.org/10.1016/j.eplepsyres.2008.12.006
Page of